Marksans Pharma

quarterly
yearly
ParticularsMar '25Jun '25Sep '25Dec '25Mar '26
Revenue723.80625.63741.98774.57891.28
Expenses607.71549.04608.65623.95691.29
EBITDA142.27105.76166.07180.89230.60
Operating Profit119.5382.67139.15156.56206.31
Profit Before Tax116.1076.60133.34150.62200.00
Net Profit90.7358.2099.14113.69149.03
Financial Ratios
Operating Profit Margin20.08%17.06%23.05%23.98%26.94%
Net Profit Margin12.78%9.41%13.64%15.00%17.30%
Earning Per Share (Diluted)2.001.292.172.503.27
Dividends Per Share0.000.000.000.000.00